Toronto dementia research alliance (TDRA) dementia clinical‐research platform: An example of research embedded into clinical care. (7th December 2020)

• Record Type: Journal Article
• Authors: Tang‐Wai, David F.; Strother, Stephen C.; Pugh, Bradley; Spring, Robyn; Vica, Carmina; Nourhaghighi, Nima; Gee, Tom; Pisterzi, Luca; Greenberg, Barry; Coahran, Margaret; Apatsidou, Areti; Ding, Jane; Kumar, Sanjeev; Black, Sandra E.; Freedman, Morris
• Is Part Of: Alzheimer's & dementia. Volume 16(2020)Supplement 11
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-12-07
• Subjects: Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1002/alz.041756
• Languages: English
• ISSNs: 1552-5260

Abstract

Abstract: Background: Dementia is arguably the greatest looming global public health challenge facing today's society and represents an international crisis as the number of affected persons will triple by 2050. Contributing to morbidity of dementia is the presence of combined pathologies, such as Alzheimer's disease (AD), cerebrovascular disease (CVD) and Parkinson's disease (PD). To address this challenge, the TDRA ‐ a collaboration of the University of Toronto's Faculty of Medicine with four University‐affiliated tertiary memory clinics ‐ created an electronic platform for research studies embedded in clinical care through development of a unified approach for diagnosis and charting of the natural history of pure and mixed dementias, along with the impact of co‐occurring disorders. Method: A detailed clinical intake form and cognitive testing (for mild‐to‐severe impairment) were created through a collaboration among behavioural neurologists, geriatricians and geriatric psychiatrists. These measures are captured electronically at point‐of‐care and, simultaneously, the deidentified information uploaded to a central research server (see Figure 1). Result: After approximately 1 year since collecting information, 1182 new patients (622 women; 560 men) have been evaluated – 119 AD; 76 concussion; 20 CBS; 8 delirium; 2 MBI, 278 MCI, 42 mixed AD and CVD; 16 PSP; 1 MSA‐P, 16 PD, 17 PD‐MCI, 21 PDD; 32 DLB; 24 bvFTD; 7 lvPPA, 13 nfPPA; 12 svPPA, 136 with primary and/or co‐morbid psychiatric disease; 165 subjective cognitive impairment; 93 VCI; 18 normal cognition; and 18 dementia NYD. Each of these patients have some demographic and clinical details, such as comorbid psychiatric and/or medical disorders, and cognitive testing obtained for research. Conclusion: The TDRA Dementia Clinical‐Research Platform is a practising example of research embedded into clinical care with over 1000 new patients with diverse diagnoses evaluated in 1 year and may represent the types of dementia seen in Toronto and surrounding areas. A letter, based on the clinical intake form, is being programmed to send back to the referring physician and will enhance clinical care, along with scores and graphic display of the cognitive testing results.